TY - JOUR
KW - diagnostic time window
KW - Hodgkin lymphoma
KW - primary care
KW - Risk
KW - Steroids
AU - M. Rafiq
AU - G. Abel
AU - C. Renzi
AU - G. Lyratzopoulos
AD - Epidemiology of Cancer Healthcare & Outcomes (ECHO), Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, UCL, London, UK; Centre for Cancer Research and Department of General Practice, University of Melbourne, Melbourne, Australia. Electronic address: Meena.rafiq@ucl.ac.uk.
University of Exeter Medical School, Exeter, UK.
Epidemiology of Cancer Healthcare & Outcomes (ECHO), Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, UCL, London, UK; Faculty of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
Epidemiology of Cancer Healthcare & Outcomes (ECHO), Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, UCL, London, UK.
AN - 36370656
BT - Cancer Epidemiol
DO - 10.1016/j.canep.2022.102284
DP - NLM
ET - 2022/11/13
LA - eng
N1 - 1877-783x
Rafiq, Meena
Abel, Gary
Renzi, Cristina
Lyratzopoulos, Georgios
Journal Article
Netherlands
Cancer Epidemiol. 2022 Nov 9;81:102284. doi: 10.1016/j.canep.2022.102284.
PY - 2022
SN - 1877-7821
EP - 102284
T2 - Cancer Epidemiol
TI - Steroid prescribing in primary care increases prior to Hodgkin lymphoma diagnosis: A UK nationwide case-control study
VL - 81
ER -